Privia Health Gr (NASDAQ:PRVA) Stock

Privia Health Gr

Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.

Privia Health Group

Earnings

Earnings Misses

Mid Cap

News

Penny Stocks

Health Care

Markets

Analyst Ratings

Trading Ideas

General

CCLD

PRVA

Privia Health (NASDAQ: PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.06 per share a year ago. These figures are adjusted for non-recurring items.

Privia Health Lags Q2 Earnings Estimates

Hilton hotel sign

Long Ideas

Insider Trades

Pre-Market Outlook

Insiders Buying Hilton Worldwide And 2 Other Stocks

Small Cap

Intraday Update

Movers

ACON

ARVL

BFRG

CDLX

CONNEXA SPORTS TECH INC by Connexa Sports Technologies Inc.

CNXA

CRBP

New Oriental Education & Technology Group

EOLS

LCID

MDAI

MMAT

MNSO

NYXH

ONMD

PALI

PBLA

REVB

RVSN

SLNA

SNCE

SOFI

SXTP

VLCN

ZAPP

Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering.

Panbela Therapeutics shares dipped 65.5% to $1.47 on Monday.

Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Privia Health Group Inc

Claros Mortgage Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMTG#NYSE">CMTG</a>) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.10 by 80 percent. This is a 30.77 percent decrease over earnings of $0.26 per share from the same period last year. The company reported quarterly sales of $60.23 million which beat the analyst consensus estimate of $56.28 million by 7.01 percent. This is a 20.73 percent decrease over sales of $75.98 million the same period last year.

Earnings Beats

CMTG

Claros Mortgage Trust Q4 2024 Adj EPS $0.18 Beats $0.10 Estimate, Sales $60.23M Beat $56.28M Estimate

Grand Canyon Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOPE#NASDAQ">LOPE</a>) is looking for Q4 Adj EPS of $3.05-$3.22. sees sales of $301.000 million-$311.500 million.

Guidance

LOPE

Grand Canyon Education Sees Q4 Adj EPS $3.05-$3.22; Sees Sales $301.000M-$311.500M

Grand Canyon Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOPE#NASDAQ">LOPE</a>) is looking for Q3 Adj EPS of $1.61-$1.74 vs $1.61 analyst estimate. sees sales of $250.500 million-$257.500 million vs $255.40 million analyst estimate.

Grand Canyon Education Sees Q3 Adj EPS $1.61-$1.74 vs $1.61 Est; Sees Sales $250.500M-$257.500M vs $255.40M Est

Grand Canyon Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOPE#NASDAQ">LOPE</a>) is looking for Q2 Adj EPS of $1.28-$1.36 vs $1.35 analyst estimate. sees sales of $236.500 million-$240.500 million vs $241.00 million analyst estimate.

Grand Canyon Education Sees Q2 Adj EPS $1.28-$1.36 vs $1.35 Est; Sees Sales $236.500M-$240.500M vs $241.00M Est

Grand Canyon Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOPE#NASDAQ">LOPE</a>) is looking for Q1 Adj EPS of $2.50-$2.52 vs $2.48 analyst estimate. sees sales of $286.500 million-$287.500 million vs $284.00 million analyst estimate.

Grand Canyon Education Sees Q1 Adj EPS $2.50-$2.52 vs $2.48 Est; Sees Sales $286.500M-$287.500M vs $284.00M Est

Grand Canyon Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOPE#NASDAQ">LOPE</a>) is looking for FY2025 Adj EPS of $8.43-$8.82 vs $8.77 analyst estimate. sees sales of $1.075 billion-$1.097 billion vs $1.09 billion analyst estimate.

Grand Canyon Education Sees FY2025 Adj EPS $8.43-$8.82 vs $8.77 Est; Sees Sales $1.075B-$1.097B vs $1.09B Est

Innovative Ind Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIPR#NYSE">IIPR</a>) reported quarterly earnings of $2.22 per share which beat the analyst consensus estimate of $2.04 by 8.82 percent. This is a 2.63 percent decrease over earnings of $2.28 per share from the same period last year. The company reported quarterly sales of $76.74 million which beat the analyst consensus estimate of $76.44 million by 0.39 percent. This is a 3.05 percent decrease over sales of $79.16 million the same period last year.

IIPR

Innovative Ind Props Q4 AFFO per common share – diluted $2.22 Beats $2.04 Estimate, Total revenues $76.74M Beat $76.44M Estimate

WIIM

NRDS

NerdWallet shares are trading higher after the company reported a year-over-year increase in Q4 EPS results and beat its revenue estimate. Additionally, the company issued Q1 revenue guidance above estimates.

Toast, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOST#NYSE">TOST</a>) reported its fourth-quarter results after Wednesday's closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/25/02/b43829789/toast-announces-fourth-quarter-and-full-year-2024-financial-results">details from the report.&nbsp;</a>
The Details:&nbsp;Toast reported quarterly earnings of 5 cents per share which missed the analyst consensus estimate of 7 cents. Quarterly revenue came in at $1.34 billion which beat the analyst consensus estimate of $1.31 billion and is an increase over revenue of $1.04 billion from the same period last year.
The company said it added 28,000 net locations in 2024, ending the year with approximately 134,000 locations and its annualized recurring run-rate (ARR) increased 34% to over $1.6 billion as of Dec. 31, 2024. Gross Payment Volume (GPV) increased 25% year-over-year to $42.2 billion in the fourth quarter. 
Read Next: <a href="https://www.benzinga.com/news/global/25/02/43787369/us-russian-officials-begin-ukraine-peace-talks-defense-sector-stocks-rise">US, Russian Officials Begin Ukraine Peace Talks: Defense Sector Stocks Rise</a>
&#8220;Toast had a strong close to 2024, capping off a transformational year where we added a record 28,000 net locations, grew our recurring gross profit streams&nbsp;34%, delivered Adjusted EBITDA of $373 million, and achieved our first year of GAAP profitability,&#8221; said Toast CEO Aman Narang.&nbsp;
TOST Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Toast shares are up 0.15% after hours at $40.05 Wednesday.  
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/social-media/25/02/43535256/palantir-adds-elon-musks-ai-chatbot-grok-to-aip">Palantir Adds Elon Musk&#8217;s AI Chatbot Grok To AIP</a></li>
</ul>
Image: Shutterstock

Restaurants

After-Hours Center

Tech

TOST

Toast Shares Rise After Mixed Q4 Report: EPS Misses, Revenues Beat

Kaiser Aluminum (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALU#NASDAQ">KALU</a>) reported quarterly earnings of $0.33 per share which missed the analyst consensus estimate of $0.64 by 48.44 percent. This is a 45 percent decrease over earnings of $0.60 per share from the same period last year. The company reported quarterly sales of $765.00 million which beat the analyst consensus estimate of $735.15 million by 4.06 percent. This is a 5.96 percent increase over sales of $722.00 million the same period last year.

KALU

Kaiser Aluminum Q4 Adj EPS $0.33 Misses $0.64 Estimate, Sales $765.00M Beat $735.15M Estimate

Nerdwallet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRDS#NASDAQ">NRDS</a>) sees Q1 sales of $187.000 million-$193.000 million vs $181.25 million analyst estimate.

Nerdwallet Sees Q1 Sales $187.000M-$193.000M vs $181.25M Est

CVNA

Watching Carvana Co; Shares Trading Lower After Company Reported Q4 2024 Results, Traders Circulate Forward Looking Statements In SEC Filing

Offerings

Intelligent Bio Solutions Inc. - Common Stock

INBS

Intelligent Bio Solutions Announces Proposed Public Offering; Size Not Disclosed

Nerdwallet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRDS#NASDAQ">NRDS</a>) reported quarterly earnings of $0.51 per share. This is a 1800 percent increase over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $183.800 million which beat the analyst consensus estimate of $168.559 million by 9.04 percent. This is a 37.47 percent increase over sales of $133.700 million the same period last year.

Nerdwallet Q4 2024 GAAP EPS $0.51 Up From $(0.03) YoY, Sales $183.800M Beat $168.559M Estimate

Blue Owl Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OBDC#NYSE">OBDC</a>) reported quarterly earnings of $0.47 per share which beat the analyst consensus estimate of $0.46 by 2.17 percent.

OBDC

Blue Owl Capital Q4 2024 Adj. EPS $0.47 Beats $0.46 Estimate

Enovix Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVX#NASDAQ">ENVX</a>) reported fourth-quarter financial results Wednesday after the bell. Here&#8217;s a rundown <a href="https://www.benzinga.com/pressreleases/25/02/g43829987/enovix-announces-fourth-quarter-and-full-year-2024-financial-results">of the report</a>.
What Happened: Enovix reported fourth-quarter revenue of $9.72 million, beating analyst estimates of $8.77 million, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. The company reported a fourth-quarter adjusted loss of 11 cents per share, beating estimates for a loss of 18 cents per share.
Full-year 2024 revenue increased 202% year-over-year to $23.1 million, and fourth-quarter revenue neared the high end of the company&#8217;s guidance. 
Enovix said it shipped early engineering samples to its lead smartphone OEM and noted that the samples have passed critical safety tests. The company remains on track to launch commercial smartphone batteries in 2025.
&#8220;The top milestones we identified at the beginning of 2024 were achieving SAT for agility and our high-volume manufacturing lines in Malaysia and delivering samples of our leading smartphone batteries, EX-1M and EX-2M, to customers,&#8221; the company said.
&#8220;Not only did we hit these top milestones, we also advanced relationships with market leaders in smartphones, AR/VR, and automotive industries. We believe that these relationships, supported by purchase orders and commercial launch schedules, provide a clear path for us to commence mass production in 2025.&#8221;
Enovix ended the quarter with $272.9 million in cash and cash equivalents. 
See Also: <a href="https://www.benzinga.com/25/02/43828018/baidus-ai-cloud-robotaxi-growth-and-accelerated-buybacks-position-it-for-a-strong-2025-analyst">Baidu&#8217;s AI Cloud, Robotaxi Growth And Accelerated Buybacks Position It For Strong 2025: Analyst</a>
What&#8217;s Next: Enovix expects first-quarter revenue to be between $3.5 million and $5.5 million versus estimates of $6.17 million, per&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>. The company anticipates a first-quarter adjusted loss of 15 to 21 cents per share versus estimates for a loss of 18 cents per share.
&#8220;2025 is off to a fast start, fueled by accelerating AI innovation and a shifting landscape that is driving OEMs to diversify their supply chains. As a leader in high-energy-density battery technology with manufacturing facilities in Korea and Malaysia, Enovix is well positioned to capitalize on these industry trends,&#8221; the company said.
Enovix executives will hold a conference call to further discuss the quarter with investors and analysts at 5 p.m. ET.
ENVX Price Action: <a href="http://benzinga.com/quote/envx" target="_blank" rel="noreferrer noopener">Enovix shares</a> were down 8.9% after hours, trading at $10.20 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Photo: Shutterstock.

ENVX

Enovix Stock Tumbles On Q4 Earnings: Revenue Beat, EPS Beat, Soft Guidance, Mass Production On Track For 2025

Okeanis Eco Tankers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECO#NYSE">ECO</a>) reported quarterly earnings of $0.41 per share which beat the analyst consensus estimate of $0.22 by 86.36 percent. This is a 34.92 percent decrease over earnings of $0.63 per share from the same period last year. The company reported quarterly sales of $85.19 million which beat the analyst consensus estimate of $82.46 million by 3.31 percent. This is a 7.07 percent decrease over sales of $91.67 million the same period last year.

Okeanis Eco Tankers Q4 Adj EPS $0.41 Beats $0.22 Estimate, Sales $85.19M Beat $82.46M Estimate

LUNG

Pulmonx shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY25 sales guidance above estimates.

The Company anticipates mid-single digit RevPAR growth in the first quarter, with January comparable hotel RevPAR growth up 9.5% over 2024. For the remaining three quarters, the Company anticipates RevPAR growth in the low single digits.

Host Hotels & Resorts Expects FY25 Total revenues Of $5.996B - $6.102B  (Est $5.819B), Adjusted FFO Per Share Of $1.82 - $1.91 (Est $1.96)

VMEO

Vimeo shares are trading lower after the company reported worse-than-expected Q1 EPS results and issued Q1 sales guidance below estimates.

Press Releases

Privia Health to Report First Quarter 2024 Results on Thursday, May 9

Privia Health Reports First Quarter 2024 Financial Results

Privia Health to Participate in the William Blair Growth Stock Conference

Privia Receives HFMA's MAP Award for High Performance in Revenue Cycle for Performance Year 2023

Privia Health to Report Second Quarter 2024 Results on Thursday, August 8

Privia Health Reports Second Quarter 2024 Financial Results

Privia Health to Report Third Quarter 2024 Results on Thursday, November 7

Privia Health Reports 2023 Performance Results in the Medicare Shared Savings Program

Privia Health Reports Third Quarter 2024 Financial Results

Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27

Addus HomeCare Corporation - Common Stock

Addus HomeCare

Agilon Health

Amedisys

Astrana Health

Aveanna Healthcare Holdings Inc. - Common Stock

Aveanna Healthcare Hldgs

BrightSpring Health Services, Inc. - Common Stock

BrightSpring Health

Chemed

Cigna

CorVel

CVS Health

Quest Diagnostics Incorporated Common Stock

Quest Diagnostics

DaVita

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)

Comments

Privia Health Gr

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga